Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 11 records, 2 pages
Search For: Androstenedione
Global Androstenedione Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Androstenedione market size was valued at USD 205.7 million in 2023 and is forecast to a readjusted size of USD 247.5 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Global 4-Androstenedione Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Chemical & Material
According to our (Global Info Research) latest study, the global 4-Androstenedione market size was valued at USD 180.1 million in 2023 and is forecast to a readjusted size of USD 216.7 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Global Androstenedione API Supply, Demand and Key Producers, 2024-2030
28 Sep 2024
Pharma & Healthcare
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
Global Androstenedione API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
28 Sep 2024
Pharma & Healthcare
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
Global 4-Androstenedione API Supply, Demand and Key Producers, 2024-2030
11 Jun 2024
Pharma & Healthcare
4-androstenedione, or androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
Global 4-Androstenedione API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
11 Jun 2024
Pharma & Healthcare
4-androstenedione, or androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
Global Androstenedione and Derivatives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Oct 2024
Pharma & Healthcare
Androstenedione and Derivatives
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
Global Androstenedione and Derivatives Supply, Demand and Key Producers, 2024-2030
02 Oct 2024
Pharma & Healthcare
Androstenedione and Derivatives
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
Global Androstenedione Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
USD3480.00
Add To Cart
Global 4-Androstenedione Supply, Demand and Key Producers, 2023-2029
24 Feb 2023
Chemical & Material
The global 4-Androstenedione market size is expected to reach $ 216.7 million by 2029, rising at a market growth of 2.7% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Androstenedione
Total: 11 records, 2 pages
Global Androstenedione Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Androstenedione market size was valued at USD 205.7 million in 2023 and is forecast to a readjusted size of USD 247.5 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global 4-Androstenedione market size was valued at USD 180.1 million in 2023 and is forecast to a readjusted size of USD 216.7 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
4-androstenedione, or androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
4-androstenedione, or androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD3480.00
Add To Cart
Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).
USD4480.00
Add To Cart
Global Androstenedione Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
USD3480.00
Add To Cart
The global 4-Androstenedione market size is expected to reach $ 216.7 million by 2029, rising at a market growth of 2.7% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>